Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
Wolff D, Herzberg PY, Herrmann A, Pavletic SZ, Heussner P, Mumm F, Höfer C, Hilgendorf I, Hemmati PG, Holler E, Greinix H, Mitchell SA. Wolff D, et al. Among authors: hilgendorf i. Bone Marrow Transplant. 2021 Oct;56(10):2618. doi: 10.1038/s41409-021-01404-9. Bone Marrow Transplant. 2021. PMID: 34413472 Free PMC article. No abstract available.
Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.
Wolff D, Wilhelm S, Hahn J, Gentilini C, Hilgendorf I, Steiner B, Kahl C, Junghanss C, Hartung G, Casper J, Uharek L, Holler E, Freund M. Wolff D, et al. Among authors: hilgendorf i. Bone Marrow Transplant. 2006 Sep;38(6):445-51. doi: 10.1038/sj.bmt.1705454. Bone Marrow Transplant. 2006. PMID: 16951692 Clinical Trial.
Autoantibody-mediated agranulocytosis in association with chronic GVHD.
Ruck S, Hilgendorf I, Müller-Hilke B, Kiefel V, Junghanss C, Freund M, Greinix H, Wolff D. Ruck S, et al. Among authors: hilgendorf i. Bone Marrow Transplant. 2008 Sep;42(5):359-60. doi: 10.1038/bmt.2008.173. Epub 2008 Jun 23. Bone Marrow Transplant. 2008. PMID: 18574447 No abstract available.
The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
Holler E, Rogler G, Brenmoehl J, Hahn J, Greinix H, Dickinson AM, Socie G, Wolff D, Finke J, Fischer G, Jackson G, Rocha V, Hilgendorf I, Eissner G, Marienhagen J, Andreesen R. Holler E, et al. Among authors: hilgendorf i. Int J Immunogenet. 2008 Aug;35(4-5):381-4. doi: 10.1111/j.1744-313X.2008.00795.x. Int J Immunogenet. 2008. PMID: 18976442
Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease.
Landfried K, Bataille F, Rogler G, Brenmoehl J, Kosovac K, Wolff D, Hilgendorf I, Hahn J, Edinger M, Hoffmann P, Obermeier F, Schoelmerich J, Andreesen R, Holler E. Landfried K, et al. Among authors: hilgendorf i. Clin Exp Immunol. 2010 Jan;159(1):87-92. doi: 10.1111/j.1365-2249.2009.04049.x. Epub 2009 Nov 11. Clin Exp Immunol. 2010. PMID: 19912254 Free PMC article.
219 results